131 related articles for article (PubMed ID: 37415325)
1. Investigating theobromine as a potential anti-human coronaviral agent.
Li J; Wang Y; Rajpoot S; Lavrijsen M; Pan Q; Li P; Baig MS
Microbiol Immunol; 2023 Sep; 67(9):404-412. PubMed ID: 37415325
[TBL] [Abstract][Full Text] [Related]
2. Repurposing dyphylline as a pan-coronavirus antiviral therapy.
Wang Y; Rajpoot S; Li P; Lavrijsen M; Ma Z; Hirani N; Saqib U; Pan Q; Baig MS
Future Med Chem; 2022 May; 14(10):685-699. PubMed ID: 35387498
[No Abstract] [Full Text] [Related]
3. Antivirals for Broader Coverage against Human Coronaviruses.
Outteridge M; Nunn CM; Devine K; Patel B; McLean GR
Viruses; 2024 Jan; 16(1):. PubMed ID: 38275966
[TBL] [Abstract][Full Text] [Related]
4. Differing pan-coronavirus antiviral potency of boceprevir and GC376 in vitro despite discordant molecular docking predictions.
Wang Y; Li P; Lavrijsen M; Li Y; Ma Z; Peppelenbosch MP; Baig MS; Pan Q
Arch Virol; 2022 Apr; 167(4):1125-1130. PubMed ID: 35171357
[TBL] [Abstract][Full Text] [Related]
5. Nirmatrelvir exerts distinct antiviral potency against different human coronaviruses.
Li J; Wang Y; Solanki K; Atre R; Lavrijsen M; Pan Q; Baig MS; Li P
Antiviral Res; 2023 Mar; 211():105555. PubMed ID: 36791846
[TBL] [Abstract][Full Text] [Related]
6. An overview on the seven pathogenic human coronaviruses.
Kesheh MM; Hosseini P; Soltani S; Zandi M
Rev Med Virol; 2022 Mar; 32(2):e2282. PubMed ID: 34339073
[TBL] [Abstract][Full Text] [Related]
7. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses.
Lawrenz J; Xie Q; Zech F; Weil T; Seidel A; Krnavek D; van der Hoek L; Münch J; Müller JA; Kirchhoff F
Clin Infect Dis; 2022 Aug; 75(1):e653-e661. PubMed ID: 35079775
[TBL] [Abstract][Full Text] [Related]
8. Immunodetection assays for the quantification of seasonal common cold coronaviruses OC43, NL63, or 229E infection confirm nirmatrelvir as broad coronavirus inhibitor.
Weil T; Lawrenz J; Seidel A; Münch J; Müller JA
Antiviral Res; 2022 Jul; 203():105343. PubMed ID: 35598779
[TBL] [Abstract][Full Text] [Related]
9. Cytopathic Effect Assay and Plaque Assay to Evaluate
Hu Y; Ma C; Wang J
Bio Protoc; 2022 Feb; 12(3):e4314. PubMed ID: 35284599
[TBL] [Abstract][Full Text] [Related]
10. Brilacidin, a COVID-19 drug candidate, demonstrates broad-spectrum antiviral activity against human coronaviruses OC43, 229E, and NL63 through targeting both the virus and the host cell.
Hu Y; Jo H; DeGrado WF; Wang J
J Med Virol; 2022 May; 94(5):2188-2200. PubMed ID: 35080027
[TBL] [Abstract][Full Text] [Related]
11. Broad antiviral and anti-inflammatory activity of Qingwenjiere mixture against SARS-CoV-2 and other human coronavirus infections.
Xie P; Fang Y; Shen Z; Shao Y; Ma Q; Yang Z; Zhao J; Li H; Li R; Dong S; Wen W; Xia X
Phytomedicine; 2021 Dec; 93():153808. PubMed ID: 34753027
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of four endemic human coronaviruses and, reactivity and neutralization capability against SARS-CoV-2 among children in the Philippines.
Sayama Y; Okamoto M; Saito M; Saito-Obata M; Tamaki R; Joboco CD; Lupisan S; Oshitani H
Sci Rep; 2023 Feb; 13(1):2310. PubMed ID: 36759702
[TBL] [Abstract][Full Text] [Related]
13. Properties of Coronavirus and SARS-CoV-2.
Malik YA
Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
[TBL] [Abstract][Full Text] [Related]
14. Development of the Safe and Broad-Spectrum Aldehyde and Ketoamide Mpro inhibitors Derived from the Constrained α, γ-AA Peptide Scaffold.
Wang L; Ma C; Sacco MD; Xue S; Mahmoud M; Calcul L; Chen Y; Wang J; Cai J
Chemistry; 2023 Jun; 29(35):e202300476. PubMed ID: 36920943
[TBL] [Abstract][Full Text] [Related]
15. Antiviral strategies against human coronaviruses.
Pyrc K; Berkhout B; van der Hoek L
Infect Disord Drug Targets; 2007 Mar; 7(1):59-66. PubMed ID: 17346212
[TBL] [Abstract][Full Text] [Related]
16. Isolation of Human Coronaviruses OC43, HKU1, NL63, and 229E in Yamagata, Japan, Using Primary Human Airway Epithelium Cells Cultured by Employing an Air-Liquid Interface Culture.
Komabayashi K; Matoba Y; Seto J; Ikeda Y; Tanaka W; Aoki Y; Ikeda T; Matsuzaki Y; Itagaki T; Shirato K; Mizuta K
Jpn J Infect Dis; 2021 Jul; 74(4):285-292. PubMed ID: 33250494
[TBL] [Abstract][Full Text] [Related]
17. Effect of Jinzhen granule on two coronaviruses: The novel SARS-CoV-2 and the HCoV-229E and the evidences for their mechanisms of action.
Ma Q; Wang Z; Chen R; Lei B; Liu B; Jiang H; Chen Z; Cai X; Guo X; Zhou M; Huang J; Li X; Dai J; Yang Z
Phytomedicine; 2022 Jan; 95():153874. PubMed ID: 34923232
[TBL] [Abstract][Full Text] [Related]
18. Mouse models susceptible to HCoV-229E and HCoV-NL63 and cross protection from challenge with SARS-CoV-2.
Liu D; Chen C; Chen D; Zhu A; Li F; Zhuang Z; Mok CKP; Dai J; Li X; Jin Y; Chen Z; Sun J; Wang Y; Li Y; Zhang Y; Wen L; Zhang Z; Zhuo J; Wang J; Ran W; Wang D; Zhang S; Tang Y; Li S; Lai X; Wei P; Yuan J; Chen F; Huang S; Sun F; Qian Z; Tan W; Zhao J; Peiris M; Zhao J
Proc Natl Acad Sci U S A; 2023 Jan; 120(4):e2202820120. PubMed ID: 36652473
[TBL] [Abstract][Full Text] [Related]
19. In Silico and In Vitro Identification of Pan-Coronaviral Main Protease Inhibitors from a Large Natural Product Library.
Shahhamzehei N; Abdelfatah S; Efferth T
Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337106
[TBL] [Abstract][Full Text] [Related]
20. More tools for our toolkit: The application of HEL-299 cells and dsRNA-nanoparticles to study human coronaviruses in vitro.
Semple SL; Alkie TN; Jenik K; Warner BM; Tailor N; Kobasa D; DeWitte-Orr SJ
Virus Res; 2022 Nov; 321():198925. PubMed ID: 36115551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
